HIV and AIDS Trial, Recruiting (NCT06069141)

HIV and AIDS Trial, Recruiting NCT06069141 Sponsor: National Taiwan University Hospital Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06069141 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People living with HIV who are 18 years of age or older and have been diagnosed with early-stage syphilis
People whose syphilis has been confirmed through two specific blood tests (called RPR and TPPA) that show signs of active infection

Who may not be able to join:

People living with HIV whose RPR blood test result is below a level of 4
People who have taken certain antibiotics (such as penicillin, some cephalosporins, doxycycline, or macrolides) in the past 4 weeks that can fight the bacteria that causes syphilis
People who have a known or suspected infection that would require treatment with those same types of antibiotics
People who have tested positive for certain other sexually transmitted infections (chlamydia or M. genitalium) and were already treated with doxycycline or a macrolide antibiotic for those infections
People who have had a bad reaction or intolerance to penicillin or doxycycline in the past
People who have already taken part in this same study before
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886-975607715

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06069141

Sponsor: National Taiwan University Hospital

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: +886-975607715

More information: https://clinicaltrials.gov/study/NCT06069141

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People living with HIV who are 18 years of age or older and have been diagnosed with early-stage syphilis
People whose syphilis has been confirmed through two specific blood tests (called RPR and TPPA) that show signs of active infection

Who may not be able to join:

People living with HIV whose RPR blood test result is below a level of 4
People who have taken certain antibiotics (such as penicillin, some cephalosporins, doxycycline, or macrolides) in the past 4 weeks that can fight the bacteria that causes syphilis
People who have a known or suspected infection that would require treatment with those same types of antibiotics
People who have tested positive for certain other sexually transmitted infections (chlamydia or M. genitalium) and were already treated with doxycycline or a macrolide antibiotic for those infections
People who have had a bad reaction or intolerance to penicillin or doxycycline in the past
People who have already taken part in this same study before
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National Taiwan University Hospital

Registry

ClinicalTrials.gov

Start date

1 January 2024

Est. completion

31 December 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Serologic response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov